FIT to Grow Old - Functionality of the Immune System and Healthy Aging
NCT ID: NCT05940337
Last Updated: 2024-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
156 participants
OBSERVATIONAL
2020-11-11
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Innate Immunity and Aging Study
NCT03944603
Promoting Immune Health by Intermittent Fasting: a Pilot Study
NCT05898360
Impact of Aging on Cytokine Production by Innate Immune Cells
NCT02660723
MicroRNA Regulation of Chronic Inflammation During Aging
NCT05392582
Fasting Effects on Metabolism and Immunity Study in Human
NCT06779201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: The primary aim of this study is to extensively characterize immune cell fitness in the elderly population to distinguish immunologically fit elderly from the unfit. Since immune cell fitness is a new concept, we will define a good immune cell fitness state using a young adult study population. Using a follow-up visit, we will evaluate whether our measure of immune cell fitness is robust and stable over time. Furthermore, to identify potential nutritional strategies to improve immune cell fitness and work towards personalized approaches, we will study the effects of metabolites and nutrients on their ability to improve immune cell fitness in monocytes from the elderly.
Study design: The study will be a cross-sectional study in which we will compare the immune cell fitness state of elderly people using young adult people to define an 'immune fit' status. Immune cell fit-ness will be measured in monocytes, which will be obtained from blood samples. Subjects will be given a standardized meal which they consume in the evening before the study visit at latest 8.00 pm. After consumption of the meal, subjects are not allowed to eat or drink anything but water.
On the study day, before the start of blood sampling, a small blood sample via a finger prick is collected to measure CRP levels. CRP levels of ≥10.0 mg/L indicate severe infection and will consequently exclude the subject from participating on that specific day. The relevant subjects are asked to make a new appointment. If CRP levels are \< 10 mg/L, blood sampling will continue.
Blood sampling and anthropometric measurements including body weight, waist and hip circumference and a DEXA scan will be performed in each subject, after which the subjects will receive breakfast. Subjects will fill in an FFQ to gain insights into regular dietary intake. In addition, subjects will fill in questionnaires on sleep quality and general health.
Elderly subjects will be contacted for a follow-up visit at least 6 months and the latest 18 months after the study visit. The study-design of the follow-up visit will be similar to the first study visit, including the standardized meal the evening before, overnight fast, blood sampling, anthropometric measurements (except for the DEXA-scan, this will only be performed as a link between immune cell fitness and fat distribution is found in the first part of the study), and questionnaires. The freshly collected blood sample will be used for our secondary aims, namely 1) to study the effects of nutrients and metabolites on immune cell fitness, and 2) to test whether our measure of immune cell fitness is robust and stable over time.
Update August 2023 Based on our preliminary results, we decided to cancel the follow-up visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elderly
No interventions assigned to this group
Young adults
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5 - 25 kg/m2 (young adults); 20 - 30 kg/m2 (elderly)
* Willing to fast overnight for 12 hours
* Willing to give a blood sample
* Having a general practitioner
* Signed informed consent
Exclusion Criteria
* Current diagnosis of cancer
* Regular use of medication that interferes with immune function (e.g. corticosteroids, cytokine blockers)
* Regular use of medication that may interfere with metabolism (e.g. metabolic inhibitors or activators)
* Use of medication that interferes with immune function and metabolism in at least one week preceding the study visit (e.g. NSAID, anti-histamines, corticosteroids)
* More than 4kg weight gain or weight loss over the last 4 months
* Vaccination within 3 months preceding the study visit (e.g. immunization against influ-enza, pneumonia, and travel-related infections)
* Donated blood within 2 months preceding the study visit
* Pregnant, lactating or wishing to become pregnant in the period between the screening and study visit (self-reported)
* Regular use of hard drugs and soft drugs (i.e. weekly use) and at least no use within 2 months preceding the study visit
* Excessive alcohol use (i.e. \>14 units per week)
* Use of cigarettes and other tobacco products
* Participation in another study that involves an intervention 2 months preceding the study visit
* Members of the research team
* Working, or doing an internship or thesis at the division "Human Nutrition and Health", Wageningen University
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Top Consortium for Knowledge and Innovation (TKI) Argi & Food
UNKNOWN
Mead Johnson Nutrition
INDUSTRY
Hycult Biotech
UNKNOWN
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lydia A. Afman
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lydia Afman
Role: PRINCIPAL_INVESTIGATOR
Wageningen University
Rinke Stienstra
Role: PRINCIPAL_INVESTIGATOR
Wageningen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Human Nutrition & Health, Wageningen University
Wageningen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Smeehuijzen L, Vrieling F, Jansen J, van der Zande HJP, Houslay TM, Gross G, van Diepen JA, Afman LA, Stienstra R. Lactate Secretion by Monocytes as a Determinant of Innate Immune Cell Fitness in Healthy Elderly. Aging Cell. 2025 Oct 13:e70220. doi: 10.1111/acel.70220. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL70696.081.19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.